Karen Shoos Lipton Net Worth & Insider Trades

Karen Shoos Lipton - Director, Celldex Therapeutics, Inc

As of June 23, 2011

What is Karen Shoos Lipton's Net Worth?

The current estimated net worth of Celldex Therapeutics, Inc's Director, Karen Shoos Lipton, is estimated to be about $2.22M . Karen Shoos Lipton owns about 3,000 units of Celldex Therapeutics, Inc common stock. In the last 2 years at Celldex Therapeutics, Inc, Karen Shoos Lipton has sold an estimated value of $0 worth.

What is Karen Shoos Lipton's Past Insider Trading?

Karen Shoos Lipton's largest purchase order was 3,000 units , worth over $11.22K on September 16, 2010. In total, Karen Shoos Lipton has made about 4 transactions over 2 years of their time at Celldex Therapeutics, Inc. Karen Shoos Lipton usually trades in September, with the busiest year in 2010.

Karen L Shoos

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

What is Karen Shoos Lipton's' Mailing Address?

  • Mailing address is 8101 Glenbrook Road Bethesda MD 20814 MD

Celldex Therapeutics, Inc Executive Compensation

Name
Year
Other Earnings Plans or Compensations
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Change in Pension Value
Other Compensation
Total
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/744218/000110465921055589/tm212386-1_def14a.htm

What are Celldex Therapeutics, Inc's Past Insider Trades?

Celldex Therapeutics, Inc's most recent insider trade came on December 9, 2022 by Tibor Keler who sold 16,860 units worth $622.61K . In the last 14 years, insiders at Celldex Therapeutics, Inc have sold an estimated value of $32.29M and bought an estimated value of $5.89M worth of shares. Insider trading is most common in June, with the busiest year in 2018. The most active traders at the company are Gerald McMahon, Director,  Anthony S Marucci, PRESIDENT & CEO,  and Avery W Catlin, Sr. VP & CFO .

Celldex Therapeutics, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...